nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—TERT—malignant glioma	0.784	1	CbGaD
Zidovudine—SLC22A8—choroid plexus—malignant glioma	0.00849	0.286	CbGeAlD
Zidovudine—TERT—embryo—malignant glioma	0.00348	0.117	CbGeAlD
Zidovudine—Pigmentation disorder—Temozolomide—malignant glioma	0.003	0.0467	CcSEcCtD
Zidovudine—TERT—central nervous system—malignant glioma	0.00161	0.054	CbGeAlD
Zidovudine—Myopathy—Temozolomide—malignant glioma	0.00143	0.0222	CcSEcCtD
Zidovudine—Hyperaesthesia—Temozolomide—malignant glioma	0.00128	0.0199	CcSEcCtD
Zidovudine—TERT—brain—malignant glioma	0.00128	0.0429	CbGeAlD
Zidovudine—Rigors—Temozolomide—malignant glioma	0.00123	0.0191	CcSEcCtD
Zidovudine—Drug interaction—Carmustine—malignant glioma	0.00112	0.0174	CcSEcCtD
Zidovudine—TK1—central nervous system—malignant glioma	0.00111	0.0372	CbGeAlD
Zidovudine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.0011	0.0171	CcSEcCtD
Zidovudine—Hearing impaired—Temozolomide—malignant glioma	0.00105	0.0164	CcSEcCtD
Zidovudine—Musculoskeletal pain—Temozolomide—malignant glioma	0.00101	0.0158	CcSEcCtD
Zidovudine—Neuropathy—Carmustine—malignant glioma	0.000974	0.0151	CcSEcCtD
Zidovudine—ABCC5—retina—malignant glioma	0.000944	0.0318	CbGeAlD
Zidovudine—Aplastic anaemia—Temozolomide—malignant glioma	0.000941	0.0146	CcSEcCtD
Zidovudine—Neuropathy—Temozolomide—malignant glioma	0.000941	0.0146	CcSEcCtD
Zidovudine—Gynaecomastia—Carmustine—malignant glioma	0.000928	0.0144	CcSEcCtD
Zidovudine—SLC29A2—cerebellum—malignant glioma	0.000894	0.0301	CbGeAlD
Zidovudine—TK1—brain—malignant glioma	0.000878	0.0295	CbGeAlD
Zidovudine—Phlebitis—Carmustine—malignant glioma	0.000874	0.0136	CcSEcCtD
Zidovudine—ABCC5—telencephalon—malignant glioma	0.000869	0.0292	CbGeAlD
Zidovudine—Deafness—Temozolomide—malignant glioma	0.000814	0.0126	CcSEcCtD
Zidovudine—SLC29A2—brain—malignant glioma	0.000726	0.0244	CbGeAlD
Zidovudine—Affect lability—Temozolomide—malignant glioma	0.000716	0.0111	CcSEcCtD
Zidovudine—Mood swings—Temozolomide—malignant glioma	0.000689	0.0107	CcSEcCtD
Zidovudine—ABCC5—medulla oblongata—malignant glioma	0.000683	0.023	CbGeAlD
Zidovudine—Breast disorder—Temozolomide—malignant glioma	0.000658	0.0102	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000655	0.0102	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000655	0.0102	CcSEcCtD
Zidovudine—Dysphagia—Carmustine—malignant glioma	0.000651	0.0101	CcSEcCtD
Zidovudine—Dysphagia—Temozolomide—malignant glioma	0.000629	0.00978	CcSEcCtD
Zidovudine—ABCC5—midbrain—malignant glioma	0.000624	0.021	CbGeAlD
Zidovudine—Pancytopenia—Carmustine—malignant glioma	0.000618	0.00961	CcSEcCtD
Zidovudine—Sweating increased—Temozolomide—malignant glioma	0.000613	0.00953	CcSEcCtD
Zidovudine—Neutropenia—Carmustine—malignant glioma	0.000609	0.00946	CcSEcCtD
Zidovudine—Pancytopenia—Temozolomide—malignant glioma	0.000597	0.00929	CcSEcCtD
Zidovudine—Dysuria—Temozolomide—malignant glioma	0.000588	0.00914	CcSEcCtD
Zidovudine—Neutropenia—Temozolomide—malignant glioma	0.000588	0.00914	CcSEcCtD
Zidovudine—Pollakiuria—Temozolomide—malignant glioma	0.000581	0.00903	CcSEcCtD
Zidovudine—Weight decreased—Temozolomide—malignant glioma	0.000569	0.00885	CcSEcCtD
Zidovudine—Neuropathy peripheral—Carmustine—malignant glioma	0.000569	0.00884	CcSEcCtD
Zidovudine—Stomatitis—Carmustine—malignant glioma	0.000566	0.00879	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000556	0.00864	CcSEcCtD
Zidovudine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00055	0.00855	CcSEcCtD
Zidovudine—Stomatitis—Temozolomide—malignant glioma	0.000547	0.0085	CcSEcCtD
Zidovudine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00053	0.00825	CcSEcCtD
Zidovudine—Sinusitis—Temozolomide—malignant glioma	0.000526	0.00818	CcSEcCtD
Zidovudine—Connective tissue disorder—Carmustine—malignant glioma	0.000512	0.00796	CcSEcCtD
Zidovudine—Hepatitis—Temozolomide—malignant glioma	0.000503	0.00783	CcSEcCtD
Zidovudine—Pharyngitis—Temozolomide—malignant glioma	0.0005	0.00777	CcSEcCtD
Zidovudine—Urinary tract disorder—Temozolomide—malignant glioma	0.000497	0.00773	CcSEcCtD
Zidovudine—Connective tissue disorder—Temozolomide—malignant glioma	0.000495	0.00769	CcSEcCtD
Zidovudine—Urethral disorder—Temozolomide—malignant glioma	0.000494	0.00767	CcSEcCtD
Zidovudine—ABCC5—cerebellum—malignant glioma	0.000483	0.0162	CbGeAlD
Zidovudine—Erythema multiforme—Temozolomide—malignant glioma	0.000476	0.0074	CcSEcCtD
Zidovudine—Cardiac disorder—Temozolomide—malignant glioma	0.000467	0.00726	CcSEcCtD
Zidovudine—SLC22A7—brain—malignant glioma	0.000466	0.0157	CbGeAlD
Zidovudine—Mental disorder—Carmustine—malignant glioma	0.000456	0.0071	CcSEcCtD
Zidovudine—Mediastinal disorder—Temozolomide—malignant glioma	0.000454	0.00705	CcSEcCtD
Zidovudine—Malnutrition—Carmustine—malignant glioma	0.000454	0.00705	CcSEcCtD
Zidovudine—Erythema—Carmustine—malignant glioma	0.000454	0.00705	CcSEcCtD
Zidovudine—Chills—Temozolomide—malignant glioma	0.000452	0.00702	CcSEcCtD
Zidovudine—SLC22A6—brain—malignant glioma	0.00045	0.0151	CbGeAlD
Zidovudine—Mental disorder—Temozolomide—malignant glioma	0.000441	0.00686	CcSEcCtD
Zidovudine—Back pain—Carmustine—malignant glioma	0.000439	0.00682	CcSEcCtD
Zidovudine—Erythema—Temozolomide—malignant glioma	0.000438	0.00681	CcSEcCtD
Zidovudine—Malnutrition—Temozolomide—malignant glioma	0.000438	0.00681	CcSEcCtD
Zidovudine—CYP2A6—cerebellum—malignant glioma	0.000433	0.0146	CbGeAlD
Zidovudine—ABCB1—blood vessel—malignant glioma	0.000432	0.0145	CbGeAlD
Zidovudine—Dysgeusia—Temozolomide—malignant glioma	0.000429	0.00667	CcSEcCtD
Zidovudine—ABCG2—telencephalon—malignant glioma	0.000425	0.0143	CbGeAlD
Zidovudine—Tremor—Carmustine—malignant glioma	0.000425	0.00661	CcSEcCtD
Zidovudine—Back pain—Temozolomide—malignant glioma	0.000424	0.00659	CcSEcCtD
Zidovudine—Anaemia—Carmustine—malignant glioma	0.000419	0.00652	CcSEcCtD
Zidovudine—Tremor—Temozolomide—malignant glioma	0.000411	0.00638	CcSEcCtD
Zidovudine—Ill-defined disorder—Temozolomide—malignant glioma	0.000407	0.00632	CcSEcCtD
Zidovudine—Leukopenia—Carmustine—malignant glioma	0.000406	0.00631	CcSEcCtD
Zidovudine—Anaemia—Temozolomide—malignant glioma	0.000405	0.0063	CcSEcCtD
Zidovudine—Angioedema—Temozolomide—malignant glioma	0.0004	0.00623	CcSEcCtD
Zidovudine—Malaise—Temozolomide—malignant glioma	0.000395	0.00614	CcSEcCtD
Zidovudine—Vertigo—Temozolomide—malignant glioma	0.000394	0.00612	CcSEcCtD
Zidovudine—Convulsion—Carmustine—malignant glioma	0.000393	0.00611	CcSEcCtD
Zidovudine—Leukopenia—Temozolomide—malignant glioma	0.000392	0.0061	CcSEcCtD
Zidovudine—ABCC5—brain—malignant glioma	0.000392	0.0132	CbGeAlD
Zidovudine—Myalgia—Carmustine—malignant glioma	0.000386	0.006	CcSEcCtD
Zidovudine—Chest pain—Carmustine—malignant glioma	0.000386	0.006	CcSEcCtD
Zidovudine—Anxiety—Carmustine—malignant glioma	0.000385	0.00598	CcSEcCtD
Zidovudine—Cough—Temozolomide—malignant glioma	0.000382	0.00595	CcSEcCtD
Zidovudine—Convulsion—Temozolomide—malignant glioma	0.00038	0.0059	CcSEcCtD
Zidovudine—Confusional state—Carmustine—malignant glioma	0.000373	0.0058	CcSEcCtD
Zidovudine—Arthralgia—Temozolomide—malignant glioma	0.000373	0.0058	CcSEcCtD
Zidovudine—Myalgia—Temozolomide—malignant glioma	0.000373	0.0058	CcSEcCtD
Zidovudine—Anxiety—Temozolomide—malignant glioma	0.000372	0.00578	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000371	0.00576	CcSEcCtD
Zidovudine—Oedema—Carmustine—malignant glioma	0.00037	0.00575	CcSEcCtD
Zidovudine—Discomfort—Temozolomide—malignant glioma	0.000369	0.00573	CcSEcCtD
Zidovudine—Thrombocytopenia—Carmustine—malignant glioma	0.000362	0.00563	CcSEcCtD
Zidovudine—Confusional state—Temozolomide—malignant glioma	0.000361	0.00561	CcSEcCtD
Zidovudine—Anaphylactic shock—Temozolomide—malignant glioma	0.000358	0.00556	CcSEcCtD
Zidovudine—Oedema—Temozolomide—malignant glioma	0.000358	0.00556	CcSEcCtD
Zidovudine—Anorexia—Carmustine—malignant glioma	0.000353	0.00548	CcSEcCtD
Zidovudine—CYP2A6—brain—malignant glioma	0.000351	0.0118	CbGeAlD
Zidovudine—Nervous system disorder—Temozolomide—malignant glioma	0.000351	0.00545	CcSEcCtD
Zidovudine—Thrombocytopenia—Temozolomide—malignant glioma	0.00035	0.00544	CcSEcCtD
Zidovudine—Skin disorder—Temozolomide—malignant glioma	0.000347	0.0054	CcSEcCtD
Zidovudine—Hyperhidrosis—Temozolomide—malignant glioma	0.000346	0.00538	CcSEcCtD
Zidovudine—ABCC4—central nervous system—malignant glioma	0.000342	0.0115	CbGeAlD
Zidovudine—Anorexia—Temozolomide—malignant glioma	0.000341	0.0053	CcSEcCtD
Zidovudine—SLC22A8—central nervous system—malignant glioma	0.00034	0.0114	CbGeAlD
Zidovudine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000337	0.00524	CcSEcCtD
Zidovudine—Insomnia—Carmustine—malignant glioma	0.000335	0.0052	CcSEcCtD
Zidovudine—ABCG2—medulla oblongata—malignant glioma	0.000334	0.0112	CbGeAlD
Zidovudine—Paraesthesia—Carmustine—malignant glioma	0.000332	0.00517	CcSEcCtD
Zidovudine—Dyspnoea—Carmustine—malignant glioma	0.00033	0.00513	CcSEcCtD
Zidovudine—Somnolence—Carmustine—malignant glioma	0.000329	0.00512	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000326	0.00507	CcSEcCtD
Zidovudine—Insomnia—Temozolomide—malignant glioma	0.000324	0.00503	CcSEcCtD
Zidovudine—Decreased appetite—Carmustine—malignant glioma	0.000322	0.005	CcSEcCtD
Zidovudine—Paraesthesia—Temozolomide—malignant glioma	0.000321	0.00499	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00032	0.00497	CcSEcCtD
Zidovudine—Dyspnoea—Temozolomide—malignant glioma	0.000319	0.00496	CcSEcCtD
Zidovudine—Somnolence—Temozolomide—malignant glioma	0.000318	0.00494	CcSEcCtD
Zidovudine—Constipation—Carmustine—malignant glioma	0.000317	0.00492	CcSEcCtD
Zidovudine—Pain—Carmustine—malignant glioma	0.000317	0.00492	CcSEcCtD
Zidovudine—Dyspepsia—Temozolomide—malignant glioma	0.000315	0.00489	CcSEcCtD
Zidovudine—Decreased appetite—Temozolomide—malignant glioma	0.000311	0.00483	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000309	0.0048	CcSEcCtD
Zidovudine—Fatigue—Temozolomide—malignant glioma	0.000308	0.00479	CcSEcCtD
Zidovudine—Constipation—Temozolomide—malignant glioma	0.000306	0.00476	CcSEcCtD
Zidovudine—Pain—Temozolomide—malignant glioma	0.000306	0.00476	CcSEcCtD
Zidovudine—ABCG2—midbrain—malignant glioma	0.000305	0.0103	CbGeAlD
Zidovudine—Feeling abnormal—Carmustine—malignant glioma	0.000305	0.00474	CcSEcCtD
Zidovudine—Gastrointestinal pain—Carmustine—malignant glioma	0.000303	0.00471	CcSEcCtD
Zidovudine—ABCG2—spinal cord—malignant glioma	0.000298	0.01	CbGeAlD
Zidovudine—Feeling abnormal—Temozolomide—malignant glioma	0.000295	0.00458	CcSEcCtD
Zidovudine—Abdominal pain—Carmustine—malignant glioma	0.000293	0.00455	CcSEcCtD
Zidovudine—Body temperature increased—Carmustine—malignant glioma	0.000293	0.00455	CcSEcCtD
Zidovudine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000292	0.00455	CcSEcCtD
Zidovudine—Urticaria—Temozolomide—malignant glioma	0.000284	0.00442	CcSEcCtD
Zidovudine—Abdominal pain—Temozolomide—malignant glioma	0.000283	0.0044	CcSEcCtD
Zidovudine—Body temperature increased—Temozolomide—malignant glioma	0.000283	0.0044	CcSEcCtD
Zidovudine—ALB—brain—malignant glioma	0.000281	0.00944	CbGeAlD
Zidovudine—ABCC4—brain—malignant glioma	0.000272	0.00914	CbGeAlD
Zidovudine—SLC22A8—brain—malignant glioma	0.00027	0.00907	CbGeAlD
Zidovudine—Asthenia—Carmustine—malignant glioma	0.000266	0.00413	CcSEcCtD
Zidovudine—ABCB1—embryo—malignant glioma	0.000258	0.00867	CbGeAlD
Zidovudine—Asthenia—Temozolomide—malignant glioma	0.000257	0.00399	CcSEcCtD
Zidovudine—Diarrhoea—Carmustine—malignant glioma	0.000253	0.00394	CcSEcCtD
Zidovudine—Pruritus—Temozolomide—malignant glioma	0.000253	0.00393	CcSEcCtD
Zidovudine—Dizziness—Carmustine—malignant glioma	0.000245	0.00381	CcSEcCtD
Zidovudine—Diarrhoea—Temozolomide—malignant glioma	0.000245	0.0038	CcSEcCtD
Zidovudine—Dizziness—Temozolomide—malignant glioma	0.000237	0.00368	CcSEcCtD
Zidovudine—ABCG2—cerebellum—malignant glioma	0.000236	0.00794	CbGeAlD
Zidovudine—Vomiting—Carmustine—malignant glioma	0.000235	0.00366	CcSEcCtD
Zidovudine—Rash—Carmustine—malignant glioma	0.000233	0.00363	CcSEcCtD
Zidovudine—Dermatitis—Carmustine—malignant glioma	0.000233	0.00362	CcSEcCtD
Zidovudine—Headache—Carmustine—malignant glioma	0.000232	0.0036	CcSEcCtD
Zidovudine—ABCB1—retina—malignant glioma	0.000228	0.00766	CbGeAlD
Zidovudine—Vomiting—Temozolomide—malignant glioma	0.000227	0.00354	CcSEcCtD
Zidovudine—Rash—Temozolomide—malignant glioma	0.000226	0.00351	CcSEcCtD
Zidovudine—Dermatitis—Temozolomide—malignant glioma	0.000225	0.0035	CcSEcCtD
Zidovudine—Headache—Temozolomide—malignant glioma	0.000224	0.00348	CcSEcCtD
Zidovudine—Nausea—Carmustine—malignant glioma	0.00022	0.00342	CcSEcCtD
Zidovudine—Nausea—Temozolomide—malignant glioma	0.000212	0.0033	CcSEcCtD
Zidovudine—ABCB1—telencephalon—malignant glioma	0.00021	0.00705	CbGeAlD
Zidovudine—CYP2C8—brain—malignant glioma	0.000197	0.00664	CbGeAlD
Zidovudine—ABCG2—brain—malignant glioma	0.000192	0.00645	CbGeAlD
Zidovudine—CYP3A4—central nervous system—malignant glioma	0.000168	0.00566	CbGeAlD
Zidovudine—ABCB1—medulla oblongata—malignant glioma	0.000165	0.00554	CbGeAlD
Zidovudine—ABCB1—midbrain—malignant glioma	0.000151	0.00506	CbGeAlD
Zidovudine—ABCB1—spinal cord—malignant glioma	0.000147	0.00494	CbGeAlD
Zidovudine—ABCB1—central nervous system—malignant glioma	0.000119	0.00401	CbGeAlD
Zidovudine—ABCB1—cerebellum—malignant glioma	0.000116	0.00392	CbGeAlD
Zidovudine—ABCB1—brain—malignant glioma	9.46e-05	0.00318	CbGeAlD
Zidovudine—ABCC4—Hemostasis—KRAS—malignant glioma	1.26e-05	0.000103	CbGpPWpGaD
Zidovudine—ALB—Metabolism—IDH1—malignant glioma	1.25e-05	0.000102	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—malignant glioma	1.24e-05	0.000102	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.23e-05	0.000101	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.23e-05	0.000101	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—BCHE—malignant glioma	1.23e-05	0.000101	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—CAV1—malignant glioma	1.23e-05	0.0001	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.23e-05	0.0001	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.22e-05	9.97e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—COX8A—malignant glioma	1.22e-05	9.97e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SPHK1—malignant glioma	1.22e-05	9.96e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.22e-05	9.94e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SPHK1—malignant glioma	1.21e-05	9.9e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP2B6—malignant glioma	1.2e-05	9.81e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP2C18—malignant glioma	1.2e-05	9.76e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—IDH2—malignant glioma	1.19e-05	9.74e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP2C18—malignant glioma	1.19e-05	9.7e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.18e-05	9.62e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CAV1—malignant glioma	1.17e-05	9.58e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—F2—malignant glioma	1.17e-05	9.57e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—FN1—malignant glioma	1.17e-05	9.57e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PIK3CA—malignant glioma	1.16e-05	9.45e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.15e-05	9.41e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTEN—malignant glioma	1.15e-05	9.36e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.13e-05	9.2e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—IDH1—malignant glioma	1.13e-05	9.19e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.13e-05	9.19e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.12e-05	9.16e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CG—malignant glioma	1.12e-05	9.15e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.12e-05	9.15e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—malignant glioma	1.12e-05	9.14e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CB—malignant glioma	1.11e-05	9.07e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—EGF—malignant glioma	1.11e-05	9.05e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PTPN11—malignant glioma	1.1e-05	8.99e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—malignant glioma	1.1e-05	8.98e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—IDH1—malignant glioma	1.1e-05	8.97e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.1e-05	8.96e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.09e-05	8.89e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SPHK1—malignant glioma	1.09e-05	8.89e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTP1—malignant glioma	1.08e-05	8.81e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTP1—malignant glioma	1.07e-05	8.72e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CG—malignant glioma	1.07e-05	8.72e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.07e-05	8.71e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SPHK1—malignant glioma	1.06e-05	8.68e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CAT—malignant glioma	1.05e-05	8.58e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AKT1—malignant glioma	1.05e-05	8.58e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP2C18—malignant glioma	1.04e-05	8.5e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CAT—malignant glioma	1.04e-05	8.49e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ASMT—malignant glioma	1.04e-05	8.48e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PPARG—malignant glioma	1.03e-05	8.42e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.03e-05	8.38e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—IDH1—malignant glioma	1.03e-05	8.38e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT2—malignant glioma	1.03e-05	8.38e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—STAT3—malignant glioma	1.02e-05	8.37e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.02e-05	8.33e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.02e-05	8.3e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.01e-05	8.21e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1e-05	8.17e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SPHK1—malignant glioma	9.93e-06	8.11e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NCOR1—malignant glioma	9.92e-06	8.1e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.91e-06	8.09e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CD—malignant glioma	9.86e-06	8.05e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.85e-06	8.04e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NCOR1—malignant glioma	9.82e-06	8.02e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTP1—malignant glioma	9.81e-06	8.01e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—BCAN—malignant glioma	9.76e-06	7.97e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP2C18—malignant glioma	9.73e-06	7.94e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	9.68e-06	7.9e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTT1—malignant glioma	9.67e-06	7.89e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTT1—malignant glioma	9.61e-06	7.85e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTEN—malignant glioma	9.6e-06	7.83e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CAT—malignant glioma	9.55e-06	7.79e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—malignant glioma	9.52e-06	7.77e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—AKT1—malignant glioma	9.46e-06	7.72e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CD—malignant glioma	9.39e-06	7.67e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—malignant glioma	9.32e-06	7.6e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.17e-06	7.49e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.16e-06	7.48e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS1—malignant glioma	9.06e-06	7.4e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.03e-06	7.37e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NCOR1—malignant glioma	9.02e-06	7.36e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS1—malignant glioma	9.01e-06	7.35e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.97e-06	7.33e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.85e-06	7.22e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—RAF1—malignant glioma	8.8e-06	7.18e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—malignant glioma	8.8e-06	7.18e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTT1—malignant glioma	8.63e-06	7.04e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CB—malignant glioma	8.59e-06	7.01e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTT1—malignant glioma	8.42e-06	6.88e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—BCHE—malignant glioma	8.42e-06	6.88e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—BCHE—malignant glioma	8.37e-06	6.84e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.36e-06	6.82e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SLC5A5—malignant glioma	8.32e-06	6.79e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	8.3e-06	6.78e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SLC5A5—malignant glioma	8.27e-06	6.75e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CB—malignant glioma	8.19e-06	6.68e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	8.17e-06	6.67e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—malignant glioma	8.11e-06	6.62e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CAV1—malignant glioma	8.09e-06	6.6e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS1—malignant glioma	8.09e-06	6.6e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PIK3CA—malignant glioma	8.09e-06	6.6e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.07e-06	6.58e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.06e-06	6.58e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CAV1—malignant glioma	8.01e-06	6.54e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS1—malignant glioma	7.89e-06	6.44e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IL2—malignant glioma	7.89e-06	6.44e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—IDH2—malignant glioma	7.87e-06	6.43e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTT1—malignant glioma	7.87e-06	6.42e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.87e-06	6.42e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.82e-06	6.39e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.8e-06	6.36e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.75e-06	6.33e-05	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	7.62e-06	6.22e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—BCHE—malignant glioma	7.52e-06	6.14e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SLC5A5—malignant glioma	7.43e-06	6.06e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.4e-06	6.04e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS1—malignant glioma	7.37e-06	6.02e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CG—malignant glioma	7.37e-06	6.01e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CAV1—malignant glioma	7.35e-06	6e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.35e-06	6e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—BCHE—malignant glioma	7.34e-06	5.99e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CG—malignant glioma	7.29e-06	5.95e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SLC5A5—malignant glioma	7.25e-06	5.92e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPARG—malignant glioma	7.11e-06	5.81e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTEN—malignant glioma	7.08e-06	5.78e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PPARG—malignant glioma	7.04e-06	5.75e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.02e-06	5.73e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.96e-06	5.68e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—BCHE—malignant glioma	6.85e-06	5.6e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.8e-06	5.55e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CA—malignant glioma	6.77e-06	5.53e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.77e-06	5.53e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—IDH1—malignant glioma	6.77e-06	5.53e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.76e-06	5.52e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—malignant glioma	6.71e-06	5.47e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTP1—malignant glioma	6.7e-06	5.47e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CG—malignant glioma	6.69e-06	5.46e-05	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.68e-06	5.45e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTP1—malignant glioma	6.66e-06	5.44e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—malignant glioma	6.6e-06	5.39e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SPHK1—malignant glioma	6.55e-06	5.35e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CAT—malignant glioma	6.52e-06	5.32e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CAT—malignant glioma	6.48e-06	5.29e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CD—malignant glioma	6.48e-06	5.29e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PPARG—malignant glioma	6.46e-06	5.27e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.42e-06	5.24e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CD—malignant glioma	6.41e-06	5.23e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.4e-06	5.23e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.34e-06	5.18e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NCOR1—malignant glioma	6.16e-06	5.03e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NCOR1—malignant glioma	6.12e-06	5e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.07e-06	4.95e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTP1—malignant glioma	5.98e-06	4.88e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CD—malignant glioma	5.88e-06	4.8e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTP1—malignant glioma	5.84e-06	4.77e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CAT—malignant glioma	5.82e-06	4.75e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—malignant glioma	5.7e-06	4.65e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CAT—malignant glioma	5.68e-06	4.64e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CB—malignant glioma	5.65e-06	4.61e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—malignant glioma	5.59e-06	4.57e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CB—malignant glioma	5.59e-06	4.56e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—malignant glioma	5.54e-06	4.52e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.53e-06	4.52e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—malignant glioma	5.53e-06	4.52e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NCOR1—malignant glioma	5.5e-06	4.49e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTP1—malignant glioma	5.45e-06	4.45e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NCOR1—malignant glioma	5.37e-06	4.38e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CAT—malignant glioma	5.31e-06	4.33e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CA—malignant glioma	5.24e-06	4.28e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTT1—malignant glioma	5.19e-06	4.24e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CB—malignant glioma	5.13e-06	4.19e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—malignant glioma	5.08e-06	4.15e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—malignant glioma	5.07e-06	4.14e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CAV1—malignant glioma	5.02e-06	4.1e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NCOR1—malignant glioma	5.01e-06	4.09e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CA—malignant glioma	4.99e-06	4.07e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CAV1—malignant glioma	4.99e-06	4.07e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTEN—malignant glioma	4.88e-06	3.98e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS1—malignant glioma	4.86e-06	3.97e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTEN—malignant glioma	4.83e-06	3.94e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.8e-06	3.92e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.77e-06	3.89e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CG—malignant glioma	4.57e-06	3.73e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CG—malignant glioma	4.55e-06	3.71e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—BCHE—malignant glioma	4.52e-06	3.69e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CAV1—malignant glioma	4.48e-06	3.66e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.47e-06	3.65e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTEN—malignant glioma	4.43e-06	3.62e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARG—malignant glioma	4.41e-06	3.6e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARG—malignant glioma	4.39e-06	3.58e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CAV1—malignant glioma	4.37e-06	3.57e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.28e-06	3.49e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—malignant glioma	4.28e-06	3.49e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CAV1—malignant glioma	4.09e-06	3.34e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CG—malignant glioma	4.08e-06	3.33e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—malignant glioma	4.08e-06	3.33e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.02e-06	3.28e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CD—malignant glioma	4e-06	3.26e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CG—malignant glioma	3.98e-06	3.25e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARG—malignant glioma	3.94e-06	3.22e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.9e-06	3.19e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARG—malignant glioma	3.84e-06	3.14e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.72e-06	3.04e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTP1—malignant glioma	3.6e-06	2.94e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARG—malignant glioma	3.59e-06	2.93e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.59e-06	2.93e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.5e-06	2.86e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CD—malignant glioma	3.5e-06	2.86e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CAT—malignant glioma	3.5e-06	2.86e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CB—malignant glioma	3.48e-06	2.84e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—malignant glioma	3.47e-06	2.83e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—malignant glioma	3.45e-06	2.82e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CA—malignant glioma	3.44e-06	2.81e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CA—malignant glioma	3.41e-06	2.78e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NCOR1—malignant glioma	3.31e-06	2.7e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.27e-06	2.67e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.13e-06	2.55e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CA—malignant glioma	3.13e-06	2.55e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—malignant glioma	3.1e-06	2.53e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CB—malignant glioma	3.05e-06	2.49e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTEN—malignant glioma	3.03e-06	2.47e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—malignant glioma	3.02e-06	2.47e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTEN—malignant glioma	3.01e-06	2.46e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.85e-06	2.33e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—malignant glioma	2.83e-06	2.31e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—malignant glioma	2.81e-06	2.3e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—malignant glioma	2.78e-06	2.27e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTEN—malignant glioma	2.7e-06	2.21e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CAV1—malignant glioma	2.69e-06	2.2e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTEN—malignant glioma	2.64e-06	2.15e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—malignant glioma	2.55e-06	2.09e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTEN—malignant glioma	2.46e-06	2.01e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.45e-06	2e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARG—malignant glioma	2.37e-06	1.93e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.16e-06	1.76e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.14e-06	1.74e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CA—malignant glioma	2.12e-06	1.73e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.91e-06	1.56e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.88e-06	1.54e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.86e-06	1.52e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.86e-06	1.52e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—malignant glioma	1.74e-06	1.42e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.74e-06	1.42e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—malignant glioma	1.73e-06	1.42e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTEN—malignant glioma	1.63e-06	1.33e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—malignant glioma	1.56e-06	1.27e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—malignant glioma	1.52e-06	1.24e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—malignant glioma	1.42e-06	1.16e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.15e-06	9.36e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—malignant glioma	9.37e-07	7.65e-06	CbGpPWpGaD
